NYSE:QGENLife Sciences
Is Qiagen's (QGEN) Digital PCR Expansion Quietly Redefining Its Competitive Moat in Biopharma Tools?
In mid-June 2026, QIAGEN N.V. expanded its QIAcuity digital PCR ecosystem with new gene expression assays, high-multiplex PCR kits, enhanced residual DNA testing, upgraded analysis software and increased automation options for life sciences and biopharma users.
This build-out deepens the integration between QIAcuity instruments, GeneGlobe assay content, and automated workflows, potentially making digital PCR more accessible and standardized for high-throughput and regulated...